InVivo Therapeutics (INNV)
INNV · BiotechSign PipelinePipeline Overview
- Therapeutic Focus
- SCI Neuro Repairsrc
Signal Snapshot
0
Clinical Trials (ClinicalTrials.gov aggregate)
0
Catalyst Records
5
Publications on Record
ClinicalTrials.gov aggregate as of 2026-09-29. Source
Recent Publications
- Improved transcutaneous delivery of cetirizine hydrochloride for the treatment of post-chemotherapy alopecia: Poke and emulgel approach. — Pak J Pharm Sci (2026) PMID 42770618
- Design and syntheses of 4-aminoquinoline-thiazolidinone hybrids as anti-protozoal agents. — Front Chem (2026) PMID 42769294
5 total publications tracked — view all on BiotechSign
Get real-time catalyst alerts, analyst signals, dilution risk scores, and full pipeline data for InVivo Therapeutics.
Full INNV Data Sign Up FreePrimary Sources
This page reports only records present in the BiotechSign source payload as of the generation date. It does not infer drug efficacy, clinical outcome probability, approval odds, revenue, market size, or unreported regulatory events.